Corpowell is developing biomimetics of compounds for nutraceutical and cosmetic applications. The first assets are plant-based, collagen biomimetics under the brand Vecollal, with the exact same amino-acid profile as the human one. They clinically demonstrated a similar or superior efficacy than marine and bovine collagen, the most common ones on the market. Vecollal is mainly commercialized as an ingredient to a diverse range of clients.